Ulrika Warpman Berglund
- Pharmacology top 5%
- Cholinesterase and Neurodegenerative Diseases 5
- Molecular Biology top 10%
- DNA Repair Mechanisms 10
- Nicotinic Acetylcholine Receptors Study 8
- Receptor Mechanisms and Signaling 7
- Biochemical and Molecular Research 6
- RNA modifications and cancer 6
- Melanoma and MAPK Pathways 4
- Oncology top 10%
-
- Cancer Genomics and Diagnostics 4
Ulrika Warpman Berglund
51 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 100
- Pharmacology 322
- Molecular Biology 1.2k
- Cellular and Molecular Neuroscience 240
- Oncology 314
- Cancer Research 141
Countries citing papers authored by Ulrika Warpman Berglund
This map shows the geographic impact of Ulrika Warpman Berglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrika Warpman Berglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrika Warpman Berglund more than expected).
Fields of papers citing papers by Ulrika Warpman Berglund
This network shows the impact of papers produced by Ulrika Warpman Berglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrika Warpman Berglund. The network helps show where Ulrika Warpman Berglund may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ulrika Warpman Berglund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 20 | |
| 4 | 2021 | 6 | |
| 5 | 2021 | 15 | |
| 6 | 2021 | 14 | |
| 7 | 2021 | 10 | |
| 8 | 2021 | 5 | |
| 9 | 2020 | 18 | |
| 10 | 2020 | 24 | |
| 11 | 2019 | 13 | |
| 12 | 2018 | 32 | |
| 13 | 2018 | 23 | |
| 14 | 2018 | 5 | |
| 15 | 2017 | 7 | |
| 16 | 2017 | 18 | |
| 17 | 2017 | 25 | |
| 18 | 2016 | 35 | |
| 19 | 2000 | 53 | |
| 20 | 1995 | 123 |
About Ulrika Warpman Berglund
Ulrika Warpman Berglund is a scholar working on Molecular Biology, Oncology and Cancer Research, having authored 52 papers that have together received 1.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (10 papers), Nicotinic Acetylcholine Receptors Study (8 papers), Receptor Mechanisms and Signaling (7 papers), Biochemical and Molecular Research (6 papers), RNA modifications and cancer (6 papers), Cholinesterase and Neurodegenerative Diseases (5 papers), Melanoma and MAPK Pathways (4 papers) and Cancer Genomics and Diagnostics (4 papers). The work is most often cited by research in Pharmacology (322 citations), Molecular Biology (1.2k citations) and Cellular and Molecular Neuroscience (240 citations). Ulrika Warpman Berglund has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Agneta Nordberg, Thomas Helleday, Nenad Bogdanović, Kumar Sanjiv, Ann‐Sofie Jemth, Amelia Marutle, Therese Pham, Camilla Göktürk, K. Huber and Giulio Superti‐Furga. Their work appears in journals such as Journal of Investigative Dermatology, Cancer Research, Biomolecules, Journal of Biological Chemistry and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.